Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on April 23, 2004
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
279/17/17224    most recent
M311875200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shi, C.-S.
Right arrow Articles by Kehrl, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shi, C.-S.
Right arrow Articles by Kehrl, J. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print February 12, 2004
J. Biol. Chem, 10.1074/jbc.M311875200
Submitted on October 29, 2003
Revised on February 11, 2004
Accepted on February 12, 2004

Pyk2 amplifies epidermal growth factor and c-Src-induced Stat3 activation

Chong-Shan Shi and John H. Kehrl

Laboratory of Immunoregulation, NIAID, NIH, Bethesda, MD 20892

Corresponding Author: jkehrl{at}niaid.nih.gov

Signal transducers and activators of transcription factors (STAT)mediate many of the cellular responses that occur following cytokine, growth factor, and hormone signaling. STATs are activated by tyrosine and serine phosphorylation, which normally occurs as a tightly regulated process. However, constitutively activated STATs have been found in many human tumors as well as in v-abl- and v-src transformed cell lines. Pyk2, a member of focal adhesion kinase family and can be activated by c-Src, EGF receptor (EGFR), Janus kinase (JAK) 1, tyrosine kinases, and G-protein coupled receptor signaling. While Pyk2 has been implicated in JAK-dependent activation of MAPK and Stat1, no role for Pyk2 in the activation of other STAT proteins has been ascribed. Here, we provide evidence that Pyk2 along with c-Src facilitate EGFR-mediated Stat3 activation. Pyk2 expression in HeLa cells induces Stat3-reporter gene activation and Stat3 phosphorylation on amino acid residues Y705 and S727. Together Pyk2 and c-Src potently activate Stat3, and Pyk2 enhances Stat3 induced cell proliferation. Moreover, expression of a dominant negative version of Pyk2 impairs c-Src-induced Stat3 activation and cell proliferation. The treatment of A431 cells with EGF results in the recruitment of c-Src, Pyk2 and Stat3 to the EGFR and the phosphorylation of c-Src, Pyk2, and Stat3. Expression of constructs for dominant negative forms of either Pyk2 or c-Src impair EGF induced Stat3 phosphorylation. These results indicate that Pyk2 facilitates EGFR and c-Src-mediated Stat3 activation, thereby implicating Pyk2 activation as a potential co-mediator in triggering Stat3-induced oncogenesis.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
G.-X. Shi, L. Jin, and D. A. Andres
Pituitary Adenylate Cyclase-Activating Polypeptide 38-Mediated Rin Activation Requires Src and Contributes to the Regulation of Hsp27 Signaling during Neuronal Differentiation
Mol. Cell. Biol., August 15, 2008; 28(16): 4940 - 4951.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
P. Krejci, L. Salazar, H. S. Goodridge, T. A. Kashiwada, M. J. Schibler, P. Jelinkova, L. M. Thompson, and W. R. Wilcox
STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes
J. Cell Sci., February 1, 2008; 121(3): 272 - 281.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
M. F. McCarty
Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy
Integr Cancer Ther, December 1, 2004; 3(4): 349 - 380.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement